Cargando…
[(18)F]FDG PET/CT Studies in Transgenic Hualpha-Syn (A53T) Parkinson’s Disease Mouse Model of α-Synucleinopathy
Transgenic mice line M83 that express the A53T mutant α–synuclein protein at six times the level of endogenous mice α–synuclein are a model of α-synucleinopathy found in Parkinson’s disease (PD). This Hualpha-Syn (A53T) PD model is useful in assessing non-motor deficits at earlier stages of onset of...
Autores principales: | Mondal, Rommani, Campoy, Anthony-David Tawatao, Liang, Christopher, Mukherjee, Jogeshwar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239288/ https://www.ncbi.nlm.nih.gov/pubmed/34211366 http://dx.doi.org/10.3389/fnins.2021.676257 |
Ejemplares similares
-
[(18)F]Nifene PET/CT Imaging in Mice: Improved Methods and Preliminary Studies of α4β2* Nicotinic Acetylcholinergic Receptors in Transgenic A53T Mouse Model of α-Synucleinopathy and Post-Mortem Human Parkinson’s Disease
por: Campoy, Anthony-David T., et al.
Publicado: (2021) -
Brain and Brown Adipose Tissue Metabolism in Transgenic Tg2576 Mice Models of Alzheimer Disease Assessed Using (18)F-FDG PET Imaging
por: Coleman, Robert A., et al.
Publicado: (2017) -
Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies
por: Carli, Giulia, et al.
Publicado: (2023) -
Quantitative assessment of brown adipose tissue metabolic activity and volume using (18)F-FDG PET/CT and β3-adrenergic receptor activation
por: Mirbolooki, M Reza, et al.
Publicado: (2011) -
BPOZ-2 Gene Delivery Ameliorates Alpha-Synucleinopathy in A53T Transgenic Mouse Model of Parkinson’s Disease
por: Roy, Avik, et al.
Publicado: (2016)